⌘K

Login Start Free

Home/Filings/4/0001181431-04-000302

4//SEC Filing

CLARK JAMES L 4

Accession 0001181431-04-000302

CIK 0001016169other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:42 AM ET

Size

4.5 KB

Accession

0001181431-04-000302

Insider Transaction Report

Form 4

Period: 2004-01-02

ANTARES PHARMA INCantr

Director

Transactions

Award
Option to purchase common stock
2004-01-02$1.06/sh+16,500$17,490→ 16,500 total
Exercise: $1.06From: 2005-01-02Exp: 2014-01-01→ common stock (16,500 underlying)

Documents

1 file

4
rrd27613.xmlPrimary
CHANGES IN BENEFICIAL OWNERSHIP

Issuer

ANTARES PHARMA INC

CIK 0001016169

Entity typeother

Related Parties

1

filerCIK 0001191145

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 8:42 AM ET
Size: 4.5 KB

View on SEC.gov